Portfolio Health Check
| Score Your rating score is 2.8 / 5.0 | Breakdown Strong Buy: 0 stocks Buy: 1 stock Hold: 6 stocks Sell: 1 stock Strong Sell: 1 stock |
Yesterday's Performance
| Top Gainers | Top Losers |
| SSKN: +1.97% | LGF.B: -2.65% |
| BMY: +0.59% | HP: -2.6% |
| SNY: +0.52% | LGF.A: -2.55% |
Breaking News
| | Bristol Myers' immunotherapy combo undergoes EU review for liver cancer SA News • BMY |
FEATURED: Be a better investor with Premium
Research shows that individual investors collectively underperform the market, because their decisions are often driven by emotions. Stay ahead of the curve with Seeking Alpha Premium's in-depth analysis and data-driven stock ratings.
Analysis
| Bristol-Myers Squibb - Investors Are Too Long-Term Focused The Value Portfolio • BMY |
Related Analysis
| VRP: Assessing My Floating Rate Preferred ETF As Interest Rates Set To Decrease Jeffrey Fischer, CFA • PFF |
| Why Novartis Deserves Your Attention After Q2 2024 Results ALLKA Research • BMY |
| Warner Bros. Discovery: A Major New Deal May Be Taking Shape, Is It Time To Go Long? Max Greve • LGF.A • LGF.B |
| Takeda's AI-Powered Strategy To Optimize Operations And Accelerate Its Pipeline BioCGT Investor • BMY |
If you believe this has been sent to you in error, please safely unsubscribe.
